Lyon IARC Polyomavirus Displays Transforming Activities in Primary Human Cells

• Published in: Journal of virology Vol. 96; no. 14; p. e0206121
• Main Authors: Venuti, Assunta, Romero-Medina, Maria Carmen, Melita, Giusi, Ceraolo, Maria Grazia, Brancaccio, Rosario Nicola, Sirand, Cecilia, Taverniti, Valerio, Steenbergen, Renske, Gheit, Tarik, Tommasino, Massimo
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 27.07.2022
• Subjects: Animals; Carcinogenesis; Fibroblasts - virology; Humans; Keratinocytes - virology; Merkel cell polyomavirus - genetics; Polyomavirus - genetics; Polyomavirus - metabolism; Polyomavirus Infections - virology; Sp1 Transcription Factor - metabolism; Telomerase - genetics; Transformation and Oncogenesis; Tumor Suppressor Protein p53 - metabolism; Virology; hTERT activation; p53 and pRb; Sp1 transcription factor; cellular transformation; Lyon IARC polyomavirus
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/jvi.02061-21

Several studies reported the presence of a recently discovered polyomavirus (PyV), Lyon IARC PyV (LIPyV), in human and domestic animal specimens. LIPyV has some structural similarities to well-established animal and human oncogenic PyVs, such as raccoon PyV and Merkel cell PyV (MCPyV), respectively. In this study, we demonstrate that LIPyV early proteins immortalize human foreskin keratinocytes. LIPyV LT binds pRb, accordingly cell cycle checkpoints are altered in primary human fibroblasts and keratinocytes expressing LIPyV early genes. Mutation of the pRb binding site in LT strongly affected the ability of LIPyV ER to induced HFK immortalization. LIPyV LT also binds p53 and alters p53 functions activated by cellular stresses. Finally, LIPyV early proteins activate telomerase reverse transcriptase ( ) gene expression, via accumulation of the Sp1 transcription factor. Sp1 recruitment to the promoter is controlled by its phosphorylation, which is mediated by ERK1 and CDK2. Together, these data highlight the transforming properties of LIPyV in experimental models, supporting its possible oncogenic nature. Lyon IARC PyV is a recently discovered polyomavirus that shows some structural similarities to well-established animal and human oncogenic PyVs, such as raccoon PyV and Merkel cell PyV, respectively. Here, we show the capability of LIPyV to efficiently promote cellular transformation of primary human cells, suggesting a possible oncogenic role of this virus in domestic animals and/or humans. Our study identified a novel virus-mediated mechanism of activation of telomerase reverse transcriptase gene expression, via accumulation of the Sp1 transcription factor. In addition, because the persistence of infection is a key event in virus-mediated carcinogenesis, it will be important to determine whether LIPyV can deregulate immune-related pathways, similarly to the well-established oncogenic viruses.